Skip to main content
Paul Kruszka Jr., MD, Medical Genetics, Bethesda, MD

PaulSKruszkaJr.MDMPH, FACMG

Medical Genetics Bethesda, MD

Clinical Genetics

Chief Medical Officer, GeneDx

Dr. Kruszka is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Kruszka's full profile

Already have an account?

  • Office

    35 Convent Dr
    Bldg 35; Room 1B207
    Bethesda, MD 20892
    Phone+1 301-402-9654

Education & Training

  • University of Virginia Medical Center
    University of Virginia Medical CenterResidency, Family Medicine, 1998 - 2001
  • University of Michigan Medical School
    University of Michigan Medical SchoolClass of 1998

Certifications & Licensure

  • DC State Medical License
    DC State Medical License 2021 - 2024
  • VA State Medical License
    VA State Medical License 1998 - 2024
  • DE State Medical License
    DE State Medical License 2001 - 2007
  • NC State Medical License
    NC State Medical License 2000 - 2000
  • American Board of Family Medicine Family Medicine
  • American Board of Medical Genetics and Genomics Clinical Genetics and Genomics

Publications & Presentations

PubMed

Press Mentions

  • New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic Yields
    New GeneDx Study Reveals Racial Disparities in Genetic Diagnosis Due to Systemic Barriers, Not Diagnostic YieldsNovember 7th, 2024
  • GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual Meeting
    GeneDx to Highlight Key Research Findings at American Society of Human Genetics (ASHG) Annual MeetingNovember 4th, 2024
  • Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn Screening
    Groundbreaking GUARDIAN Study Shows Benefits of Adding Genome Sequencing to Newborn Screening; Augments and Improves Standard Newborn ScreeningOctober 24th, 2024
  • Join now to see all